These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9673752)

  • 1. Calcitriol in osteoporosis--is it used safely?
    Mathur G; Clifton-Bligh P; Fulcher G; Stiel J; McElduff A
    Aust N Z J Med; 1998 Jun; 28(3):348-9. PubMed ID: 9673752
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of osteoporosis with vitamin D.
    Kanis JA; McCloskey EV; de Takats D; Bernard J; Zhang DM
    Osteoporos Int; 1997; 7 Suppl 3():S140-6. PubMed ID: 9536320
    [No Abstract]   [Full Text] [Related]  

  • 3. Can hypercalcaemia be avoided during oral calcitriol pulse therapy of secondary hyperparathyroidism in haemodialysis patients?
    Szotkiewicz M; Zdrojewski Z; Swima-Gillow A; Rutkowski B
    Nephrol Dial Transplant; 1995; 10(9):1781-2. PubMed ID: 8559511
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic effects of synthetic calcitriol (Rocaltrol) in the treatment of postmenopausal osteoporosis.
    Gallagher JC
    Metabolism; 1990 Apr; 39(4 Suppl 1):27-9. PubMed ID: 2325568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercalcemia caused by vitamin D3 analogs in psoriasis treatment.
    Braun GS; Witt M; Mayer V; Schmid H
    Int J Dermatol; 2007 Dec; 46(12):1315-7. PubMed ID: 18173537
    [No Abstract]   [Full Text] [Related]  

  • 6. Reduced risk of hypercalcemia for hemodialysis patients by administering calcitriol at night.
    Schaefer K; Umlauf E; von Herrath D
    Am J Kidney Dis; 1992 May; 19(5):460-4. PubMed ID: 1585935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limitations of pulse oral calcitriol therapy in continuous ambulatory peritoneal dialysis patients.
    Bechtel U; Mücke C; Feucht HE; Schiffl H; Sitter T; Held E
    Am J Kidney Dis; 1995 Feb; 25(2):291-6. PubMed ID: 7847357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Serum calcium concentration and the safety of vitamin D therapy].
    Ikeda Y; Takemoto F
    Clin Calcium; 2004 Sep; 14(9):79-82. PubMed ID: 15577116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of calcitriol in the treatment of postmenopausal osteoporosis.
    Aloia JF
    Metabolism; 1990 Apr; 39(4 Suppl 1):35-8. PubMed ID: 2182976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,25(OH)2 vitamin D for osteoporosis.
    Rosen H
    Ann Intern Med; 1991 Mar; 114(6):519-20. PubMed ID: 1994801
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term treatment with calcitriol in postmenopausal osteoporosis.
    Caniggia A; Nuti R; Lore F; Martini G; Turchetti V; Righi G
    Metabolism; 1990 Apr; 39(4 Suppl 1):43-9. PubMed ID: 2325571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of daily and intermittent-dose calcitriol on serum parathyroid hormone and ionized calcium concentrations in normal cats and cats with chronic renal failure.
    Hostutler RA; DiBartola SP; Chew DJ; Nagode LA; Schenck PA; Rajala-Schultz PJ; Drost WT
    J Vet Intern Med; 2006; 20(6):1307-13. PubMed ID: 17186842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose calcitriol versus calcium in established postmenopausal osteoporosis.
    Tilyard M
    Metabolism; 1990 Apr; 39(4 Suppl 1):50-2. PubMed ID: 2325572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of postmenopausal osteoporosis with calcitriol or calcium.
    Tilyard MW; Spears GF; Thomson J; Dovey S
    N Engl J Med; 1992 Feb; 326(6):357-62. PubMed ID: 1729617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study 1,25-dihydroxycholecalciferols and 24,25-dihydroxycholecalciferols effect on ionized calcium level in blood plasma of patients with osteoporosis].
    Khodyrev VN; Spirichev VB
    Vopr Pitan; 2005; 74(2):15-9. PubMed ID: 15921199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of continuous alendronate, cyclical alendronate and cyclical etidronate with calcitriol in the treatment of postmenopausal vertebral osteoporosis: a randomized controlled trial.
    Sahota O; Fowler I; Blackwell PJ; Lawson N; Cawte SA; San P; Masud T; Hosking DJ
    Osteoporos Int; 2000; 11(11):959-66. PubMed ID: 11193249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoparathyroidism: Less Severe Hypocalcemia With Treatment With Vitamin D2 Compared With Calcitriol.
    Streeten EA; Mohtasebi Y; Konig M; Davidoff L; Ryan K
    J Clin Endocrinol Metab; 2017 May; 102(5):1505-1510. PubMed ID: 28324108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study.
    Gallagher JC; Goldgar D
    Ann Intern Med; 1990 Nov; 113(9):649-55. PubMed ID: 2221645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevations in serum and urinary calcium with parathyroid hormone (1-84) with and without alendronate for osteoporosis.
    Antoniucci DM; Sellmeyer DE; Bilezikian JP; Palermo L; Ensrud KE; Greenspan SL; Black DM
    J Clin Endocrinol Metab; 2007 Mar; 92(3):942-7. PubMed ID: 17164314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism.
    Sprague SM; Llach F; Amdahl M; Taccetta C; Batlle D
    Kidney Int; 2003 Apr; 63(4):1483-90. PubMed ID: 12631365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.